Text-Based Smoking Cessation Program for Rural Cancer Survivors
Trial Summary
What is the purpose of this trial?
This phase III trial compares the effect of text-based cessation intervention to a manual in helping rural cancer patients who smoke, quit. Text-based scheduled gradual reduction may reduce the frequency of cigarette use to zero and may be effective in quitting smoking.
Will I have to stop taking my current medications?
The trial requires that you are not currently using any smoking cessation medications like nicotine replacement therapy, bupropion, or varenicline. Other medications are not mentioned, so it's best to discuss with the trial team.
What data supports the effectiveness of the Text-Based Smoking Cessation Program for Rural Cancer Survivors treatment?
Research shows that text messaging programs are effective for helping people quit smoking. Studies have found that these programs improve smoking abstinence in the general population and are feasible and acceptable for rural older adults, making them a promising option for rural cancer survivors.12345
Is the Text-Based Smoking Cessation Program safe for humans?
How is the Text-Based Smoking Cessation Program for Rural Cancer Survivors different from other smoking cessation treatments?
The Text-Based Smoking Cessation Program is unique because it uses automated text messages to support quitting smoking, making it easily accessible and feasible for rural cancer survivors who may have limited access to traditional in-person programs. This approach can enhance motivation and provide ongoing support, which is particularly beneficial for those in remote areas.13467
Research Team
Devon Noonan, PhD, MPH, FNP-BC
Principal Investigator
Duke School of Nursing
Eligibility Criteria
This trial is for rural cancer survivors who currently smoke at least 5 cigarettes daily, have had a cancer diagnosis within the last decade, and may still be undergoing treatment. Participants must be adults with texting-capable phones, not using smoking cessation drugs or programs, able to read English, and willing to provide a urine sample.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants participate in a scheduled gradual reduction program over 8 weeks, receiving cessation support messages via text messages for 12 weeks
Follow-up
Participants are monitored for smoking cessation and quality of life at 6 months post-quit date
Treatment Details
Interventions
- Text-Based Cessation Intervention (Behavioral Intervention)
Text-Based Cessation Intervention is already approved in China for the following indications:
- Smoking cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Alliance for Clinical Trials in Oncology
Lead Sponsor
Suzanne George
Alliance for Clinical Trials in Oncology
Chief Medical Officer since 2015
MD from Harvard Medical School
Evanthia Galanis
Alliance for Clinical Trials in Oncology
Chief Executive Officer since 2022
MD from Mayo Clinic
National Cancer Institute (NCI)
Collaborator
Dr. Douglas R. Lowy
National Cancer Institute (NCI)
Chief Executive Officer since 2023
MD from New York University School of Medicine
Dr. Monica Bertagnolli
National Cancer Institute (NCI)
Chief Medical Officer since 2022
MD from Harvard Medical School